Women's Health
Read Avalere experts’ analysis and research findings on how coverage, care, and outcomes related to women’s health and health services are shaped by policymakers, industry, plans, and advocates.
Most Women with Cervical Cancer Were Not Screened Before Diagnosis
An Avalere analysis shows that those who had received cervical cancer screening within five years prior to diagnosis were diagnosed at relatively younger ages.
Video: The Impact of Caregiving on Mental Health
In the first installment of our women's health video series, Avalere sits down with Dr. Madhavi Vemireddy of caregiving platform Cleo to discuss the impact caregiving can have on one’s mental health.
Addressing Sex and Gender Disparities in Cognitive Health
Women are more likely to experience reduced cognitive health later in life. Recent federal efforts seek to address the paucity of research on this phenomenon.
Technology Is Driving Innovation in Women’s Health
The FemTech industry is rapidly growing and evolving as health equity and women’s health research become a larger focus and target priority in the US.
Breast Cancer Screening Recommendations May Drive Inequities
New USPSTF breast cancer screening recommendations may not address the disparities experienced by Black women.
Cervical Cancer Screening Rates Differ Across Demographics
The majority of women are not receiving cervical cancer screenings in compliance with recommendations, with disparities by insurance and age.
Stakeholders Address Disparities in Breast Cancer Screening
Avalere found disparate breast cancer screening rates by race/ethnicity and insurance type. Stakeholders are seeking to address barriers to patient access.
6 Ways the Mifepristone Rulings May Impact Future FDA Approvals
Conflicting court rulings regarding FDA approval of mifepristone, part of the regimen for medication abortion, may set a new precedent for product approvals.
After Roe, Growing Fertility Industry Faces Risks at State Level
Despite market growth, fertility services may be affected by the overturning of Roe v. Wade. The extent and nature of impact will vary by state.
10 Questions on Dobbs v. Jackson’s Reproductive Health Impact and More
Uncertainty related to the Dobbs ruling could have downstream effects on reproductive healthcare that go beyond abortion.
Avalere Data on Breast Cancer Screening Disparities Published in AJMC
Avalere analysis conducted in collaboration with the Community Oncology Alliance (COA) was published in the American Journal of Managed Care, showing disparities in breast cancer screening rates during the COVID-19 pandemic among racial and ethnic minority groups and based on insurance type.
Patient Preferences in Triple Negative Breast Cancer Treatments
To determine the attributes of triple-negative breast cancer treatment that play a direct role in patient treatment decision making at treatment initiation and following initial treatment selection, Avalere conducted focus groups to examine treatment experiences of patients with triple-negative breast cancer and elicit their treatment-related preferences.
Reducing Maternal Mortality Among Women of Color
Women of color are disproportionately affected by pregnancy-related death in the US, which has a higher maternal mortality rate than 10 other developed nations worldwide.
Interview: Obstetric Quality Terminology by AAPI Subgroups and Equitable Patient Engagement
Tune into our first episode of Avalere’s Journal Club Review podcast series on Avalere Health Essential Voice. In this segment, Courtney Ramus, Consultant in the Center for Healthcare Transformation and Jasmine Nicole Namata, Associate in the Associate Immersion Program discuss the findings, themes, and relevant application of a contemporary healthcare publication.
4 Key Takeaways from USPSTF Recommendations for BRCA-Related Cancers & Risk-Reducing Medications
Announced this past August, the US Preventive Services Task Force (USPSTF) expanded risk assessment and genetic testing recommendations for BRCA-related cancers and recommendations for risk-reducing therapies. This expansion marks the growing importance of genetic literacy in the healthcare system.
Testing Proves Usefulness of Avalere Shared Decision-Making Tool to Women with Advanced Breast Cancer
In 2018, Avalere partnered with CancerCare and Gabrielle Rocque, an oncologist at the University of Alabama Birmingham School of Medicine, to develop the Preparation for Shared Decision Making (PFSDM) tool.
New Avalere Analysis Compares Varying Breast Cancer Screening Recommendations
In October, the American Cancer Society (ACS) released its recommendations for breast cancer screening. The guidelines, which apply to women with average breast cancer risk, recommend annual screening from age 45 to 54, with biennial screening recommended for women over age 55. This represents a notable departure from its 2003 guideline, which advocated annual mammography for women at age 40 and older. The dramatic change in screening recommendation is in line with the growing evidence of benefits and harms of breast cancer screening. However, varying guidelines from organizations, such as the U.S. Preventive Services Task Force (USPSTF) and National Comprehensive Cancer Network (NCCN) reveal that experts have not come to a complete agreement on this issue.
Updated Breast Cancer Screening Recommendation Could Eliminate Guaranteed Coverage of Mammography for 17M Women
A new analysis from Avalere finds that 17 million women ages 40 to 49 could lose their guarantee of mammogram coverage, if new breast cancer screening guidelines from the United States Preventive Services Task Force (USPSTF) are finalized.
USPSTF Revisits Controversial Mammography Screening Recommendations
On Nov. 14, the U.S. Preventive Services Task Force (USPSTF) released a draft research plan for Public Comment on "Screening for Breast Cancer," which intends to re-evaluate the effectiveness of routine mammography screening in women age 40 and older.